戻る Agendas
Session 1207 Drug-Diagnostic Co-Development and Regulatory Requirement and Challenges for Companion Diagnostic Test
Session Chair(s)
Jinjie Hu, PHD
Co-Chair of FDAAA International Network Committee, Senior Consultant
Biologics Consulting Group, United States
Speaker(s)
Changhua Chen
GCP CLINPLUS, China
-
Xiaomeng Liu
GCP Clinplus, China
-
Personalized Medicine The Role of Biomarker for Clinical Treatment Decision
Zhiyang Zhang
3G Biotech, China
-
Regulatory Implications for Personalized Medicines and Companion Diagnostics
James Creeden, DrMed, PHD
Creeden Consulting, Switzerland
Principal
Juanjuan An
CFDA, China